Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs

Author： Sommerville K.W.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.10, 2003-01, pp. : 661-670

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Divalproex to Divalproex Extended Release Conversion

By Sandeep Dutta   Ronald C. Reed  

Clinical Drug Investigation, Vol. 24, Iss. 9, 2004-01 ,pp. : 495-508

Adis International

Access to resources Recommend Favorite

Functional Half-Life is a Meaningful Descriptor of Steady-State Pharmacokinetics of an Extended-Release Formulation of a Rapidly Cleared Drug: As Shown by Once-Daily Divalproex-ER

By Dutta Sandeep   Reed Ronald C.  

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 681-690

Adis International

Access to resources Recommend Favorite

Divalproex sodium extended-release for the prophylaxis of migraine headache

By Freitag Fred G  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1573-1578

Informa Healthcare

Access to resources Recommend Favorite

Influence of Enzyme-Inducing Antiepileptic Drugs on Trough Level of Imatinib in Glioblastoma Patients

By  

Current Clinical Pharmacology, Vol. 3, Iss. 3, 2008-09 ,pp. : 198-203

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Extended Release Divalproex Sodium Tablets Containing Hypdrophobic and Hydrophilic Matrix

By  

Current Drug Delivery, Vol. 6, Iss. 3, 2009-07 ,pp. : 291-296

Bentham Science Publishers

Access to resources Recommend Favorite